Management of anticoagulation and factor XIII replacement in a patient with severe factor XIII deficiency and recurrent venous thromboembolic disease: case report and review of literatureRESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASISIF3.42024-02-011OAAI
Plasma levels of mannan-binding lectin-associated serine proteases are increased in type 1 diabetes patients with insulin resistanceCLINICAL AND EXPERIMENTAL IMMUNOLOGYIF3.82023-10-131OAAI
Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levelsFRONTIERS IN IMMUNOLOGYIF5.92023-09-133OAAI
Complement lectin pathway components MBL and MASP-1 promote haemostasis upon vessel injury in a microvascular bleeding modelFRONTIERS IN IMMUNOLOGYIF5.92022-08-127OAAI
Exploring the function of factor XIII free B subunit: Interactions with complement factors and a novel approach to identify potential binding partnersRESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASISIF3.42022-07-013OAAI
Basic science research opportunities in thrombosis and hemostasis: Communication from the SSC of the ISTHJOURNAL OF THROMBOSIS AND HAEMOSTASISIF52022-06-015OAAI
An international collaborative study to assign value for Total Factor XIII-B Subunit Antigen to the WHO 1st International Standard for Factor XIII Plasma, (02/206): Communication from the ISTH SSC Subcommittee on Factor XIII and FibrinogenJOURNAL OF THROMBOSIS AND HAEMOSTASISIF52022-02-012PRE
Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic新型冠状病毒肺炎大流行前脑静脉窦血栓形成患者的血小板减少症和血小板因子4/肝素抗体的频率JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552021-07-2733OA
Illustrated State-of-the-Art Capsules of the ISTH 2021 CongressRESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASISIF3.42021-07-011OAAI
Prediction of cerebral venous thrombosis with a new clinical score and D-dimer levelsNEUROLOGYIF8.52020-08-1819OAAI
MASP-1 of the complement system alters fibrinolytic behaviour of blood clotsMOLECULAR IMMUNOLOGYIF32019-10-0113PREAI
Enhanced Thrombolysis by Ultrasound-Assisted Catheter-Directed Thrombolysis and Microbubbles in an In Vitro Model of Iliofemoral Deep Vein ThrombosisTHROMBOSIS AND HAEMOSTASISIF4.32019-06-0520PREAI
Proline 36 of the Factor XIII Activation Peptide Plays a Crucial Role in Substrate Recognition and Zymogen ActivationTHROMBOSIS AND HAEMOSTASISIF4.32018-11-126OAAI
A diabetic microvascular flow model as a new tool to examine the role of complement in diabetes-associated vascular complicationsMOLECULAR IMMUNOLOGYIF32018-10-010PREAI
Identification of a novel nonsense mutation leading to congenital factor XIII deficiencyTHROMBOSIS RESEARCHIF3.42018-05-013OAAI
Acquired factor XIII deficiency: a therapeutic challengeTHROMBOSIS AND HAEMOSTASISIF4.32017-11-2942PREAI
TAFI activity in coronary artery disease: A contribution to the current discussion on TAFI assaysTHROMBOSIS AND HAEMOSTASISIF4.32017-11-2820PREAI
International Registry on Factor XIII Deficiency: A basis formed mostly on European dataTHROMBOSIS AND HAEMOSTASISIF4.32017-11-27126PREAI
Factor XIII activation peptide is released into plasma upon cleavage by thrombin and shows a different structure compared to its bound formTHROMBOSIS AND HAEMOSTASISIF4.32017-11-2732PRE